Esters of quinoxaline-7-carboxylate-1,4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors

Palos, Isidro; Moo-Puc, Rosa; Vique-Sánchez, José Luis; Benítez-Cardoza, Claudia G.; Monge, Antonio; Villalobos-Rocha, Juan Carlos; Paz-Gonzalez, Alma D.; Rivera, Gildardo

doi:10.2478/acph-2021-0032

Abstract

Trichomoniasis is a public health problem worldwide. Trichomoniasis treatment consists of the use of nitroimidazole derivatives; however, therapeutic ineffectiveness occurs in 5 to 20 % of the cases. Therefore, it is essential to propose new pharmacological agents against this disease. In this work, esters of quinoxaline-7-carboxylate-1,4-di-N-oxide (EQX-NO) were evaluated in in vitro assays as novel trichomonicidal agents. Additionally, an in vitro enzyme assay and molecular docking analysis against triosephosphate isomerase of Trichomonas vaginalis to confirm their mechanism of action were performed. Ethyl (compound 12) and n-propyl (compound 37) esters of quinoxaline-7-carboxy-late-1,4-di-N-oxide derivatives showed trichomonicidal activity comparable to nitazoxanide, whereas five methyl (compounds 5, 15, 19, 20 and 22), four isopropyl (compounds 28, 29, 30 and 34), three ethyl (compounds 4, 13 and 23) and one npropyl (compound 35) ester derivatives displayed activity comparable to albendazole. Compounds 6 and 20 decreased 100 % of the enzyme activity of recombinant protein triosephosphate isomerase.

References

1. D. Leitsch, Drug resistance in the microaerophilic parasite Giardia lamblia, Curr. Trop. Med. Rep.2 (2015) 128–135; https://doi.org/10.1007/s40475-015-0051-110.1007/s40475-015-0051-1452369426258002
Search in Google Scholar Back to article
2. B. R. Ansell, M. J. McConville, S. Y. Ma’ayeh, M. J. Dagley, R. B. Gasser, S. G. Svärd and A. R. Jex, Drug resistance in Giardia duodenalis, Biotechnol. Adv.33 (2015) 888–901; https://doi.org/10.1016/j.biotechadv.2015.04.00910.1016/j.biotechadv.2015.04.00925922317
Search in Google Scholar Back to article
3. C. B. Menezes, A. P. Frasson and T. Tasca, Trichomoniasis – are we giving the deserved attention to the most common non-viral sexually transmitted disease worldwide?, Microb. Cell3 (2016) 404–419; https://doi.org/10.15698/mic2016.09.52610.15698/mic2016.09.526535456828357378
Search in Google Scholar Back to article
4. D. Leitsch, Recent advances in the Trichomonas vaginalis field, F1000Res.5 (2016) Article ID 162 (7 pages); https://doi.org/10.12688/f1000research.7594.110.12688/f1000research.7594.1475539626918168
Search in Google Scholar Back to article
5. P. Kissinger, Trichomonas vaginalis: a review of epidemiologic, clinical and treatment issues, BMC Infect. Dis.15 (2015) Article ID 307 (8 pages); https://doi.org/10.1186/s12879-015-1055-010.1186/s12879-015-1055-0452574926242185
Search in Google Scholar Back to article
6. P. Upcroft and J. A. Upcroft, Drug targets and mechanisms of resistance in the anaerobic protozoa, Clin. Microbiol. Rev.14 (2001) 150–164; https://doi.org/10.1128/CMR.14.1.150-164.200110.1128/CMR.14.1.150-164.20018896711148007
Search in Google Scholar Back to article
7. P. A. Cano, A. Islas-Jácome, J. González-Marrero, L. Yépez-Mulia, F. Calzada and R. Gámez-Montaño, Synthesis of 3-tetrazolylmethyl-4H-chromen-4-ones via Ugi-azide and biological evaluation against Entamoeba histolytica, Giardia lamblia and Trichomona vaginalis, Bioorg. Med. Chem.22 (2014) 1370–1376; https://doi.org/10.1016/j.bmc.2013.12.06910.1016/j.bmc.2013.12.06924468633
Search in Google Scholar Back to article
8. S. Chaturvedi, M. Y. Malik, M. Rashid, S. Singh, V. Tiwari, P. Gupta, S. Shukla, S. Singh and M. Wahajuddin, Mechanistic exploration of quercetin against metronidazole induced neurotoxicity in rats: possible role of nitric oxide isoforms and inflammatory cytokines, Neurotoxicology79 (2020) 1–10; https://doi.org/10.1016/j.neuro.2020.03.00210.1016/j.neuro.2020.03.00232151614
Search in Google Scholar Back to article
9. J. Jampilek, Recent advances in design of potential quinoxaline anti-infectives, Curr. Med. Chem.21 (2014) 4347–4373; https://doi.org/10.2174/092986732166614101119482510.2174/092986732166614101119482525312209
Search in Google Scholar Back to article
10. I. Balderas-Renteria, P. Gonzalez-Barranco, A. Garcia, B. K. Banik and G. Rivera, Anticancer drug design using scaffolds of β-lactams, sulfonamides, quinoline, quinoxaline and natural products. Drugs advances in clinical trials, Curr. Med. Chem.19 (2012) 4377–4398; https://doi.org/10.2174/09298671280325159310.2174/09298671280325159322709002
Search in Google Scholar Back to article
11. N. B. Patel, J. N. Patel, A. C. Purohit, V. M. Patel, D. P. Rajani, R. Moo-Puc, J. C. Lopez-Cedillo, B. Nogueda-Torres and G. Rivera, In vitro and in vivo assessment of newer quinoxaline-oxadiazole hybrids as antimicrobial and antiprotozoal agents, Int. J. Antimicrob. Agents50 (2017) 413–418; https://doi.org/10.1016/j.ijantimicag.2017.04.01610.1016/j.ijantimicag.2017.04.01628687457
Search in Google Scholar Back to article
12. G. Cheng, W. Sa, C. Cao, L. Guo, H. Hao, Z. Liu, X. Wang and Z. Yuan, Quinoxaline 1,4-di-N-oxides: Biological activities and mechanisms of actions, Front. Pharmacol.7 (2016) Article ID 64 (21 pages); https://doi.org/10.3389/fphar.2016.0006410.3389/fphar.2016.00064480018627047380
Search in Google Scholar Back to article
13. R. El Aissi, J. Liu, S. Besse, D. Canitrot, O. Chavignon, J. M. Chezal, E. Miot-Noirault and E. Moreau, Synthesis and biological evaluation of new quinoxaline derivatives of ICF01012 as melanoma-targeting probes, ACS Med. Chem. Lett.5 (2014) 468–473; https://doi.org/10.1021/ml400468x10.1021/ml400468x402760924900863
Search in Google Scholar Back to article
14. J. C. Villalobos-Rocha, L. Sánchez-Torres, B. Nogueda-Torres, A. Segura-Cabrera, C. A. García-Pérez, V. Bocanegra-García, I. Palos, A. Monge and G. Rivera, Anti-Trypanosoma cruzi and anti-leishmanial activity by quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives, Parasitol. Res.113 (2014) 2027–2035; https://doi.org/10.1007/s00436-014-3850-810.1007/s00436-014-3850-824691716
Search in Google Scholar Back to article
15. K. F. Chacón-Vargas, S. Andrade-Ochoa, B. Nogueda-Torres, D. C. Juárez-Ramírez, E. E. Lara-Ramírez, R. Mondragón-Flores, A. Monge and G. Rivera, L. E. Sánchez-Torres, Isopropyl quinoxaline-7-carboxylate 1,4-di-N-oxide derivatives induce regulated necrosis-like cell death on Leish-mania (Leishmania) mexicana, Parasitol. Res.117 (2018) 45–58; https://doi.org/10.1007/s00436-017-5635-310.1007/s00436-017-5635-329159705
Search in Google Scholar Back to article
16. M. Quiliano, A. Pabón, G. Ramirez-Calderon, C. Barea, E. Deharo, S. Galiano and I. Aldana, New hydrazine and hydrazide quinoxaline 1,4-di-N-oxide derivatives: In silico ADMET, antiplasmo-dial and antileishmanial activity. Bioorg. Med. Chem. Lett.27 (2017) 1820–1825; https://doi.org/10.1016/j.bmcl.2017.02.04910.1016/j.bmcl.2017.02.04928291694
Search in Google Scholar Back to article
17. B. E. Duque-Montaño, L. C. Gómez-Caro, M. Sanchez-Sanchez, A. Monge, E. Hernández-Baltazar, G. Rivera and O. Torres-Angeles, Synthesis and in vitro evaluation of new ethyl and methyl quinoxaline-7-carboxylate 1,4-di-N-oxide against Entamoeba histolytica, Bioorg. Med. Chem.21 (2013) 4550–4558; https://doi.org/10.1016/j.bmc.2013.05.03610.1016/j.bmc.2013.05.03623787289
Search in Google Scholar Back to article
18. L. C. Gómez-Caro, M. Sánchez-Sánchez, V. Bocanegra-García, A. Monge and G. Rivera, Synthesis of quinoxaline 1,4-di-N-oxide derivatives on solid support using room temperature and microwave-assisted solvent-free procedures, Quim. Nova34 (2011) 1147–1151; https://doi.org/10.1590/S0100-4042201100070000810.1590/S0100-40422011000700008
Search in Google Scholar Back to article
19. E. Hernández-Núñez, H. Tlahuext, R. Moo-Puc, H. Torres-Gómez, R. Reyes-Martínez, R Cedillo-Rivera, C. Nava-Zuazo and G. Navarrete-Vazquez, Synthesis and in vitro trichomonicidal, giardicidal and amebicidal activity of N-acetamide(sulfonamide)-2-methyl-4-nitro-1H-imidazoles, Eur. J. Med. Chem.44 (2009) 2975–2984; https://doi.org/10.1016/j.ejmech.2009.01.00510.1016/j.ejmech.2009.01.00519208443
Search in Google Scholar Back to article
20. B. R. Brooks, C. L. Brooks, A. D. Mackerell, L. Nilsson, R. J. Petrella, B. Roux, Y. Won, G. Archontis, C. Bartels, S. Boresch, A. Caflisch, L. Caves, Q. Cui, A. R. Dinner, M. Feig, S. Fischer, J. Gao, M. Hodoscek, W. Im, K. Kuczera, T. Lazaridis, J. Ma, V. Ovchinnikov, E. Paci, R. W. Pastor, C. B. Post, J. Z. Pu, M. Schaefer, B. Tidor, R. M. Venable, H. L. Woodcock, X. Wu, W. Yang, D. M. York and M. Karplus, CHARMM: The biomolecular simulation program, J. Comput. Chem.30 (2009) 1545–1614; https://doi.org/10.1002/jcc.2128710.1002/jcc.21287281066119444816
Search in Google Scholar Back to article
21. P. R. Gerber and K. Müller, MAB, a generally applicable molecular force field for structure modelling in medicinal chemistry, J. Comput. Aided Mol. Des.9 (1995) 251–268; https://doi.org/10.1007/bf0012445610.1007/BF00124456
Search in Google Scholar Back to article
22. C. A. Del Carpio, Y. Takahashi and S.-i. Sasaki, A new approach to the automatic identification of candidates for ligand receptor sites in proteins: (I) Search for pocket regions, J. Mol. Graph.11 (1993) 23–29; https://doi.org/10.1016/0263-7855(93)85003-9
Search in Google Scholar Back to article
23. A. Miranker and M. Karplus, Functionality maps of binding sites: A multiple copy simultaneous search method, Proteins: Struct. Funct. Genet.11 (1991) 29–34; https://doi.org/10.1002/prot.3401101010.1002/prot.340110104
Search in Google Scholar Back to article
24. S. Thangapandian, S. John, Y. Lee, S. Kim and K. W. Lee, Dynamic structure-based pharmacophore model development: A new and effective addition in the histone deacetylase 8 (HDAC8) inhibitor discovery, Int. J. Mol. Sci.12 (2011) 9440–9462; https://doi.org/10.3390/ijms1212944010.3390/ijms12129440
Search in Google Scholar Back to article
25. A. Wadood, M. Ghufran, S. F. Hassan, H. Khan, S. S. Azam and U. Rashid, In silico identification of promiscuous scaffolds as potential inhibitors of 1-deoxy-D-xylulose 5-phosphate reductoisom-erase for treatment of Falciparum malaria, Pharm. Biol.55 (2017) 19–32; https://doi.org/10.1080/13880209.2016.122577810.1080/13880209.2016.1225778
Search in Google Scholar Back to article
26. A. M. Clark and P. Labute, 2D depiction of protein–ligand complexes, J. Chem. Inf. Model. 47 (2007) 1933–1944; https://doi.org/10.1021/ci700147310.1021/ci7001473
Search in Google Scholar Back to article
27. S. Lara-González, P. Estrella, C. Portillo, M. E. Cruces, P. Jiménez-Sandoval, J. Fattori, A. C. Migliorini-Figueira, M. López-Hidalgo, C. Díaz-Quezada, M. López-Castillo, C. H. Trasviña-Arenas, E. Sánchez-Sandoval, A. Gómez-Puyou, J. Ortega-López, R. Arroyo, C. G. Benítez-Cardoza and L. G. Brieba, Substrate-induced dimerization of engineered monomeric variants of triosephosphate isomerase from Trichomonas vaginalis, PLoS ONE10 (2015) e0141747; https://doi.org/10.1371/journal.pone.014174710.1371/journal.pone.0141747
Search in Google Scholar Back to article
28. P. Jiménez-Sandoval, J. L. Vique-Sanchez, M. L. Hidalgo, G. Velazquez-Juarez, C. Díaz-Quezada, L. F. Arroyo-Navarro, G. M. Morán, J. Fattori, A. J. Diaz-Salazar, E. Rudiño-Pinera, R. Sotelo-Mundo, A. C. Migliorini-Figueira, S. Lara-Gonzalez, C. G. Benítez-Cardoza and L. G. Brieba, A competent catalytic active site is necessary for substrate induced dimer assembly in triosephosphate isomerase, Biochim. Biophys. Acta – Prot. Proteom.1865 (2017) 1423–1432; https://doi.org/10.1016/j.bbapap.2017.07.01410.1016/j.bbapap.2017.07.014
Search in Google Scholar Back to article
29. G. Álvarez, J. Martínez, B. Aguirre-López, N. Cabrera, L. Pérez-Díaz, M. T. de Gómez-Puyou, A. Gómez-Puyou, R. Pérez-Montfort, B. Garat, A. Merlino, M. González and H. Cerecetto, New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition, J. Enzyme Inhib. Med. Chem.29 (2014) 198–204; https://doi.org/10.3109/14756366.2013.76541510.3109/14756366.2013.765415
Search in Google Scholar Back to article
30. A. Gómez-Puyou, E. Saavedra-Lira, I. Becker, R. A. Zubillaga, A. Rojo-Dominguez and R. Perez-Montfort, Using evolutionary changes to achieve species-specific inhibition of enzyme action — studies with triosephosphate isomerase, Chem. Biol.2 (1995) 847–855; https://doi.org/10.1016/1074-5521(95)90091-810.1016/1074-5521(95)90091-8
Search in Google Scholar Back to article
31. M. de N. C. Soeiro and S. L. Castro, Screening of potential anti-Trypanosoma cruzi candidates: In vitro and in vivo studies, Open Med. Chem. J.5 (2011) 21–30; https://doi.org/10.2174/187410450110501002110.2174/1874104501105010021310389721629508
Search in Google Scholar Back to article
32. G. Álvarez, B. Aguirre-López, J. Varela, M. Cabrera, A. Merlino, G. V. López, M. L. Lavaggi, W. Porcal, R. Di Maio, M. González, H. Cerecetto, N. Cabrera, R. Pérez-Montfort, M. Tuena de Gómez-Puyou and A. Gómez-Puyou, Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity, Eur. J. Med. Chem.45 (2010) 5767–5772; https://doi.org/10.1016/j.ejmech.2010.09.03410.1016/j.ejmech.2010.09.03420889239
Search in Google Scholar Back to article
33. C. G. Benítez-Cardoza, D. A. Fernández-Velasco and J. L. Vique-Sánchez, Triosephosphate isom-erase inhibitors as potential drugs against Clostridium perfringens, Chem. Sel.5 (2020) 2365–2370; https://doi.org/10.1002/slct.20190463210.1002/slct.201904632
Search in Google Scholar Back to article
34. J. L. Vique-Sánchez, L. A. Caro-Gómez, L. G. Brieba and C. G. Benítez-Cardoza, Developing a new drug against trichomoniasis, new inhibitory compounds of the protein triosephosphate isomerase, Parasitol. Int.76 (2020) Article ID 102086; https://doi.org/10.1016/j.parint.2020.10208610.1016/j.parint.2020.102086
Search in Google Scholar Back to article
35. A. Téllez-Valencia, S. Avila-Ríos, R. Pérez-Montfort, A. Rodríguez-Romero, M. Tuena de Gómez-Puyou, F. López-Calahorra and A. Gómez-Puyou, Highly specific inactivation of triosephosphate isomerase from Trypanosoma cruzi, Biochem. Biophys. Res. Commun.295 (2002) 958–963; https://doi.org/10.1016/s0006-291x(02)00796-910.1016/S0006-291X(02)00796-9
Search in Google Scholar Back to article
36. B. Hernández-Ochoa, G. Navarrete-Vázquez, C. Nava-Zuazo, A. Castillo-Villanueva, S. T. Méndez, A. Torres-Arroyo, S. Gómez-Manzo, J. Marcial-Quino, M. Ponce-Macotela, Y. Rufino-González, M. Martínez-Gordillo, G. Palencia-Hernández, N. Esturau-Escofet, E. Calderon-Jaimes, J. Oria-Hernández and H. Reyes-Vivas, Novel giardicidal compounds bearing proton pump inhibitor scaffold proceeding through triosephosphate isomerase inactivation, Sci. Rep.7 (2017) Article ID 7810; https://doi.org/10.1038/s41598-017-07612-y10.1038/s41598-017-07612-y555269128798383
Search in Google Scholar Back to article

Esters of quinoxaline-7-carboxylate-1,4-di-N-oxide as Trichomonas vaginalis triosephosphate isomerase inhibitors

Abstract

Paradigm

My account